Melissa Sutherland

Engagement with the Government regarding the Life Science Fund seeking partnership and funding to support completion of Phase I and Phase II clinical research program associated to AMR (antimicrobial resistance) Antimicrobial Resistance (AMR) - Seek funding and support for pilot projects making anti-infective medications available to equity seeking populations, helping to combat AMR. Also discuss any applicable conditions regarding this funding. Programs and policy to support Canadian biomanufacturing and access to medicines and vaccines for Canadians. National Immunization Strategy and policies and programs that impact public access to vaccines and disease prevention in Canada. Patented Medicines Review Board (PMPRB), certified under the Patent Act and whose guidelines seek to ensure a balance between the prices set by manufacturers for patented medicines sold in Canada and the maintenance of an attractive environment for pharmaceutical research and development. Engagement with federal officials regarding the Biomanufacturing & Life Sciences Strategy and policies and programming related to biomanufacturing in Canada Access to medicines - government policies, processes, legislation, and/or regulation with potential impact on access to medicines in Canada. Trade-related matters, including policies and tariffs impacting medicines and vaccines. Policies and programs related to the health of new immigrants to Canada. Policies, programs, and funding related to Canada's Sexually Transmitted and Blood-Borne Infections (STBBI) Action Plan 2024-2030. Engagement with federal officials regarding Health Emergency Readiness Canada. The National Pharmaceutical Strategy (NPS) as agreed by First Ministers in 2004. Advocacy for ways to increase access to medicines and vaccines for Canadian patients. The Common Drug Review (CDR) process for reviewing new drugs and providing listing recommendations to publicly funded drug benefit plans in Canada. Ensuring the access needs of Canadian patients are met by advocating on activities undertaken in the context of the CDR. Science and Technology (S&T) Strategy: Mobilizing Science and Technology to Canada's Advantage. Advocacy for measures which will allow for commercialization in health care to occur and for Canada to remain competitive internationally on Intellectual Property and other fronts. Public Services and Procurement Canada (PSPC) Integrity Framework - Clarifying the process for procurement of vaccines and possibly pharmaceuticals under the evolving procurement framework. Patented Medicines (Notice of Compliance) Regulations which seek to balance the protection of Intellectual Property (IP) and patents with cost containment. Advocacy to ensure that IP rights are respected and internationally competitive in order to promote Research and Development. Legislation, regulations, policies and programs concerning the federal government's response to COVID-19, including pandemic preparedness, pharmaceutical and vaccine supply-chain management, and general administration of justice. Food and Drugs Act and the bill formerly known as Bill C-51: An Act to amend the Food and Drugs Act and to make consequential amendments to other Acts. Specifically, with respect to the renewal of the drug approval process. Advocacy to ensure that Canada's review and approval process is timely, safe, effective, competitive and consistent with other jurisdictions. FedDev Ontario Advanced Manufacturing Fund - advancing manufacturing of innovative pharmaceutical products in southern Ontario Engage with government to strengthen the Priority Review for Drug Submissions process. Engage the Government regarding the need for clear and efficient procurement processes for COVID-19 medical countermeasures, including COVID-19 therapeutics, to ensure access for Canadians. Engagement with the Government regarding the Strategic Innovation Fund Drug Re-importation - Raise awareness regarding the potential risks to drug and vaccine supply fo

Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products.

Brain Canada Foundation is seeking a top-up to its current funding to support the development and application of AI to accelerate research, advance our understanding of the brain, and identify solutions for brain diseases and disorders. Brain Canada Foundation is seeking additional funding to increase the Canada Brain Research Fund, which is currently funded by the Government of Canada, through Health Canada, and which current funding expires March 31, 2028. Brain Canada Foundation wishes to engage the Government on policy development issues related to medical research support, mental health, Indigenous health, and sex and gender diversity in the medical and research fields.

The government’s Pandemic Preparedness Strategy as it relates to the corporation’s future operations in Canada Health Canada and Public Services and Procurement Canada policies regarding the development, procurement, and distribution of Moderna’s COVID-19 vaccine to various segments of the population, including future distribution models Government policies regarding innovation, research and development, and messenger ribonucleic acid (mRNA) biotechnology

To have discussions with respect to Canadian manufacturing capacity for products under Canada’s Food and Drug regulations destined exclusively for export to international markets.

Seek funding and support for the institution’s teaching, and research and development enterprise in life sciences, basic and applied sciences, social sciences, humanities and fine arts and mental health. Support for the implementation and operation of the Canada Water Agency Support for institutional compliance with federal research security requirements. Seek program development and support for Indigenous-led research Seeking program development for career opportunities for Indigenous post-secondary graduates Seeking greater efficiencies and continued funding of the Canada Student Loan Program Seek funding for international opportunities in student experience through academic exchanges, study abroad and international student visits to Canada Secure funding for Major Science Infrastructure Policy development and research funding for knowledge transfer and the commercialization of research Increase federal funding to the Canada Graduate Scholarship Program and other national initiatives in support of graduate students Funding for research and campus infrastructure Funding for internships, fellowships and student work-integrated learning Facilitation of improved policies that impact international students and other highly qualified personnel Discuss post-secondary institutions' role in securing Canada's water future through education and research. Discuss post-secondary institutions' role in securing Canada's energy future through research and teaching. Development of a national program for the provision of long-term operating funding for major science initiatives like the Canadian Light Source (CLS) and the Vaccine and Infectious Disease Organization (VIDO) Continue and increase funding to the Tri-Agency (CIHR, NSERC, SSHRC) in order to maintain an internationally competitive research and development infrastructure. Continue and increase funding to the Indirect Costs of Research Program in order to maintain an internationally competitive research and development infrastructure Continue and increase funding to the Canada Foundation for Innovation in order to maintain an internationally competitive research and development infrastructure. Budget bills in support of the federal role in post-secondary education, research and the science and technology framework

Federal AI Adoption capability for ISED as a federal department Joint health data proposal together with research hospitals Pan-Canadian AI Compute Environment (PAICE) program progress and AI compute Bill C-27: Artificial Intelligence and Data Act (AIDA) consultation